Search
for
Sort by
Research 91–120 of 1000+
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Is dehydroepiandrosterone a hormone?
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Nonclassic adrenal hyperplasia
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Sulfatase inhibitors: a patent review
- Female type of adult acne: Physiological and psychological considerations and management
- Hair loss and herbs for treatment
- Side effects of common acne treatments
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Antiandrogen Therapy for Skin and Hair Disease
- Genetic basis of polycystic ovary syndrome
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Frontal fibrosing alopecia: a review of eleven patients
- Hyperadrenocorticism in Ferrets
- PLASMA TESTOSTERONE GLUCOSIDURONATE: A RELIABLE INDICATOR OF FEMALE HYPERANDROGENISM (IDIOPATHIC HIRSUTISM AND ANDROGENIC ALOPECIA)
- Markers of peripheral androgen action in vivo and in vitro
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Insulin Resistance and Polycystic Ovary Syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- CYP21A2 Mutations in Women with Polycystic Ovary Syndrome (PCOS)
- Influence of Saw palmetto and Pygeum africana extracts on the urinary concentrations of endogenous anabolic steroids: Relevance to doping analysis